Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...
Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...
Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...
Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
Africanews on MSN4d
DRC faces setback in fight against mpox amid ongoing fighting in eastThe Africa Centres for Disease Control and Prevention said the country saw a 31 per cent increase in cases last week.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
More than 200 community health agents have already been trained in Burundi to help control the spread of mpox as the ...
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback